Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:56 PM
Ignite Modification Date:
2025-12-24 @ 10:56 PM
NCT ID:
NCT01207869
Eligibility Criteria:
Inclusion Criteria:
* severe BPD, defined by the National Institute of Child Health and Human Development workshop, who conventional therapies (including furosemide and theophylline, and HFO ventilation) has failed
Exclusion Criteria:
* severe congenital anomalies
* severe intraventricular hemorrhage ≥ grade 3 or cystic periventricular leukomalacia.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
1 Week
Maximum Age:
6 Months
Study:
NCT01207869
Study Brief:
Protocol Section:
NCT01207869